Letter: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study

Neurosurgery. 2022 Nov 1;91(5):e135. doi: 10.1227/neu.0000000000002125. Epub 2022 Aug 24.

Samuel J Cler¹, David C Lauzier², Akash P Kansagra^{1

2

3

4}

¹ Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
² Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
³ Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
⁴ Department of Neurointerventional Surgery,California Center for Neurointerventional Surgery, San Diego, California, USA.

No abstract available

Publication types